Romanelli Joseph's Form 4 filing
Merck & Co., Inc. (MRK) · filed Aug 3, 2023
- Accession no.
- 0001127602-23-021936
- Filed
- Aug 3, 2023
- Trade date
- Aug 2, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $9.56K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Romanelli JosephCIK 0001938322 | Officer (President, Human Health Int?l) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | Common Stock | SSaleDisposed | −30 | $107.37 | −$3,221.1 | 20,569.33 | Direct | |
| Aug 2, 2023 | Common Stock | SSaleDisposed | −59 | $107.37 | −$6,334.83 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.